Alexion Pharmaceuticals, Inc.
Cerdulatinib for treating hematological cancers

Last updated:

Abstract:

Disclosed herein are methods and uses of cerdulatinib for treating diseases or conditions, including hematological cancers, and combinations of cerdulatinib for treating such diseases or conditions.

Status:
Grant
Type:

Utility

Filling date:

16 Jul 2020

Issue date:

20 Sep 2022